CT筛查检出小细胞肺癌的特征与结局
基于国家肺癌筛查试验(NLST)中143例小细胞肺癌(SCLC)患者,分析低剂量CT(LDCT)筛查检出SCLC的特征与生存。结果显示筛查检出者仍以晚期为主,筛查与间期检出或筛查后诊断者生存无显著差异,提示LDCT对SCLC的早期检出未改善结局。
要点
- LDCT筛查检出的SCLC中80%为III/IV期,晚期比例高。
- 筛查检出SCLC仅63.3%在癌所在肺叶有≥1个非钙化结节。
- 筛查检出与间期检出或筛查后诊断的SCLC生存无显著差异。
核心结论
- LDCT筛查的早期检出对SCLC结局无影响。
- 理想的筛查方法应能比LDCT更早检出SCLC。
研究设计与样本
- 国家肺癌筛查试验(NLST)为随机研究,比较LDCT与胸部X线在高危人群中的筛查效果。
- 共诊断143例SCLC,其中筛查检出49例(34.2%)、间期检出15例(10.5%)、非筛查/筛查后79例(55.2%)。
主要发现
- 筛查阶段诊断的SCLC中间期检出比例高于非小细胞肺癌(NSCLC)(23% vs 5%,P < .0001)。
- 全部SCLC中晚期(III/IV期)比例高于NSCLC(86% vs 36%,P < .0001)。
- 晚期分布见于筛查检出(80% III/IV期)、间期检出(86%)和非筛查/筛查后(90%)SCLC。
- 筛查检出的SCLC中仅63.3%在癌所在肺叶有≥1个非钙化结节,低于NSCLC的85.4%(P < .0001)。
- 即使LDCT筛查检出结节很小,SCLC晚期比例仍高;筛查检出与间期检出或筛查后SCLC生存无显著差异。
临床怎么用
- 临床应认识到LDCT筛查对SCLC早期检出和生存改善有限。
- 对于LDCT筛查发现的疑似SCLC需警惕晚期可能,即使结节较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies with a limited number of patients have reported divergent findings on whether screening can detect small cell lung cancer (SCLC) at an earlier stage and whether there might be a survival benefit. METHODS: This study examined the characteristics of SCLC detected by using low-dose CT (LDCT) screening in the National Lung Screening Trial, a randomized study of individuals at high risk for developing lung cancer comparing LDCT imaging vs chest radiography. SCLC was denoted as screen detected if diagnosed ≤ 1 year of a positive screen or after a longer period but with no time gap between diagnostic procedures of > 1 year; interval detected if diagnosed ≤ 1 year of a negative screen; and nonscreen detected if the subject did not receive any screens or otherwise as postscreening. RESULTS: A total of 143 cases of SCLC were diagnosed, including 49 (34.2%) screen detected, 15 (10.5%) interval detected, and 79 (55.2%) nonscreened/postscreening. Of the screening phase-diagnosed cases (ie, screen or interval detected), a higher proportion of SCLC cases compared with NSCLC cases were interval detected (23% vs 5%; P < .0001). A higher proportion of all SCLC cases compared with NSCLC cases were advanced stage (III/IV: 86% vs 36%; P < .0001). The unfavorable SCLC stage distribution extended across screen-detected (80% stage III/IV), interval-detected (86%), and nonscreened/postscreening (90%) cancers. Among screen-detected SCLC, only 63.3% had ≥ 1 noncalcified nodule in the cancer lobe compared with 85.4% of NSCLC cases (P < .0001). Even with very small LDCT screen-detected nodules, a high proportion of SCLC cases were late stage. There was no significant difference in survival between screen- and interval-detected or postscreening SCLC. CONCLUSIONS: "Early detection" with the use of LDCT imaging had no impact on SCLC outcomes. A successful screening modality should ideally detect SCLC earlier than when it can be detected on LDCT scans.
引用
- Thomas A, Pattanayak P, Szabo E, et al. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening. Chest. 2018. PMID: 30080997. doi:10.1016/j.chest.2018.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。